These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 4277671)

  • 1. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
    [No Abstract]   [Full Text] [Related]  

  • 2. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
    Yoda A
    Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
    Yoda A; Yoda S; Sarrif AM
    Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. IV. Dissociation rate constants for complexes of the enzyme with cardiac oligodigitoxides.
    Yoda S; Sarrif AM; Yoda A
    Mol Pharmacol; 1975 Sep; 11(5):647-52. PubMed ID: 126365
    [No Abstract]   [Full Text] [Related]  

  • 5. Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1977 Mar; 13(2):352-61. PubMed ID: 140301
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
    Tobin T; Akera T; Ku D; Lu MC
    Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible inhibition of (Na+ + K+)-ATPase with a cardiac glycoside.
    Ross CR; Pessah NI
    Eur J Pharmacol; 1975 Aug; 33(1):223-6. PubMed ID: 126168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and dissociation rate constants of the complexes between various cardiac monoglycosides and Na, K-ATPase.
    Yoda A
    Ann N Y Acad Sci; 1974; 242(0):598-616. PubMed ID: 4279608
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in cardiac glycoside-Na+,K+-ATPase interaction.
    Wallick ET; Lindenmayer GE; Lane LK; Allen JC; Pitts BJ; Schwartz A
    Fed Proc; 1977 Aug; 36(9):2214-8. PubMed ID: 142025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain.
    Yoda A; Hokin LE
    Biochem Biophys Res Commun; 1970 Aug; 40(4):880-6. PubMed ID: 4251204
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.
    Albers RW; Koval GJ; Siegel
    Mol Pharmacol; 1968 Jul; 4(4):324-36. PubMed ID: 4232893
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for two forms of fluoride-treated sodium- and potassium-dependent adenosine triphosphatase.
    Penzotti SC; Titus E
    Mol Pharmacol; 1972 Mar; 8(2):149-58. PubMed ID: 4260221
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation of contractile effect and binding and inhibition of Na+-K+-adenosine triphosphatase by cardiac glycosides in rabbit myometrium.
    Murthy RV; Kidwai AM; Daniel EE
    J Pharmacol Exp Ther; 1974 Mar; 188(3):575-81. PubMed ID: 4273912
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of pH on the interaction of cardiotonic steroids with sodium- and potasssium-dependent adenosine triphosphatase.
    Yoda A; Yoda S
    Mol Pharmacol; 1978 Jul; 14(4):624-32. PubMed ID: 28472
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model.
    Wilson WE; Sivitz WI; Hanna LT
    Mol Pharmacol; 1970 Sep; 6(5):449-59. PubMed ID: 4248266
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of cardiac glycosides of renal adenosine triphosphatase activity and Na+ reabsorption in dogs.
    Nelson JA; Nechay BR
    J Pharmacol Exp Ther; 1970 Dec; 175(3):727-40. PubMed ID: 4249913
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. I. Effects on sodium-sensitive phosphorylation and potassium-sensitive dephosphorylation.
    Banerjee SP; Wong SM; Khanna VK; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):8-17. PubMed ID: 4258649
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation of the positive inotropic action of digitalis from inhibition of sodium- and potassium-activated adenosine triphosphate.
    Okita GT; Richardson F; Roth-Schechter BF
    J Pharmacol Exp Ther; 1973 Apr; 185(1):1-11. PubMed ID: 4266379
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. V. Dissociation rate constants of digitoxin acetates.
    Yoda A; Yoda S
    Mol Pharmacol; 1975 Sep; 11(5):653-62. PubMed ID: 126366
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of phospholipids in the binding of ouabain to sodium- and potassium-dependent adenosine triphosphatase.
    Taniguchi K; Iida S
    Mol Pharmacol; 1973 May; 9(3):350-9. PubMed ID: 4267958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.